Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Antifungal drug resistance evoked through RNAi-dependent epimutations

Antifungal drug resistance evoked through RNAi-dependent epimutations

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

AB Sciex launches immunosuppressants kit to improve health care

AB Sciex launches immunosuppressants kit to improve health care

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck's NOXAFIL injection gets FDA approval for intravenous use

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Researchers explore ways to overcome transplant rejection

Researchers explore ways to overcome transplant rejection

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients